About the Product

Description


Lithozon 300 Tablet containing Lithium Carbonate is used in the management of mood disorders and related psychiatric conditions. It helps support emotional stability and long-term mental health under appropriate medical supervision.

Lithium Carbonate works by influencing neurotransmitter activity and cellular signaling pathways in the brain, helping maintain mood balance and support psychiatric treatment goals.

The tablet is widely prescribed in psychiatric practice for the long-term management of mood-related disorders, leading to consistent prescription demand.

With increasing awareness of mental health and growing demand for effective psychiatric therapies, this product offers strong business potential for retailers and distributors. Its established clinical relevance, therapeutic value, and steady market demand make it a reliable product for growth in the neuro psychiatry segment.

Important Notice: Lithium Carbonate is a prescription medicine that requires careful dose monitoring and regular medical supervision. Distribution and marketing should comply with all applicable regulatory requirements.

Some patients may experience nausea, vomiting, diarrhea, tremors, increased thirst, increased urination, weight gain, fatigue, or mild cognitive slowing. Rarely, lithium toxicity, kidney dysfunction, thyroid abnormalities, cardiac rhythm disturbances, or severe neurological effects may occur and require immediate medical attention.

Lithozon 300 Tablet is indicated for bipolar disorder, acute manic episodes, maintenance therapy for bipolar affective disorder, and other mood disorders as prescribed by a healthcare professional. It helps reduce mood swings, control manic symptoms, and prevent relapse of mood episodes.

This medicine should be used strictly under medical supervision. Regular monitoring of blood lithium levels is essential, as the therapeutic range is narrow and toxicity can occur even with modest increases in blood concentration. Kidney function, thyroid function, and electrolyte levels should also be monitored periodically. Maintain adequate fluid and salt intake unless otherwise advised by a healthcare professional. Use cautiously in patients with kidney disease, heart disease, thyroid disorders, or dehydration.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Lithium Carbonate 300mg Tablet in the PCD pharma franchise market?

Lithium Carbonate 300mg Tablet has strong demand in the psychiatry, mental health, and CNS (Central Nervous System) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neuropsychiatric and mental healthcare portfolios.

Why should medical distributors include Lithium Carbonate 300mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for mood disorder management under medical supervision. Lithium Carbonate 300mg is a mood stabilizer widely used in psychiatric practice Commonly prescribed for bipolar disorder and other mood-related psychiatric conditions as determined by healthcare professionals Helps stabilize mood and supports long-term management of recurrent mood episodes Widely utilized by psychiatrists and mental health specialists for maintenance therapy This strengthens a comprehensive psychiatric and CNS care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Lithium Carbonate 300mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady prescription demand in psychiatry practice, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the CNS segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.